JP5701371B2 - スフィンゴミエリン含有サプリメント - Google Patents

スフィンゴミエリン含有サプリメント Download PDF

Info

Publication number
JP5701371B2
JP5701371B2 JP2013268809A JP2013268809A JP5701371B2 JP 5701371 B2 JP5701371 B2 JP 5701371B2 JP 2013268809 A JP2013268809 A JP 2013268809A JP 2013268809 A JP2013268809 A JP 2013268809A JP 5701371 B2 JP5701371 B2 JP 5701371B2
Authority
JP
Japan
Prior art keywords
mass
solid supplement
supplement
tablet
sphingomyelin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013268809A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014141476A5 (cg-RX-API-DMAC7.html
JP2014141476A (ja
Inventor
陽一 新井
陽一 新井
塩屋 靖
靖 塩屋
悠記 石田
悠記 石田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2013268809A priority Critical patent/JP5701371B2/ja
Publication of JP2014141476A publication Critical patent/JP2014141476A/ja
Publication of JP2014141476A5 publication Critical patent/JP2014141476A5/ja
Application granted granted Critical
Publication of JP5701371B2 publication Critical patent/JP5701371B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2013268809A 2012-12-28 2013-12-26 スフィンゴミエリン含有サプリメント Active JP5701371B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013268809A JP5701371B2 (ja) 2012-12-28 2013-12-26 スフィンゴミエリン含有サプリメント

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012288219 2012-12-28
JP2012288219 2012-12-28
JP2013268809A JP5701371B2 (ja) 2012-12-28 2013-12-26 スフィンゴミエリン含有サプリメント

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014258323A Division JP2015083594A (ja) 2012-12-28 2014-12-22 スフィンゴミエリン含有サプリメント

Publications (3)

Publication Number Publication Date
JP2014141476A JP2014141476A (ja) 2014-08-07
JP2014141476A5 JP2014141476A5 (cg-RX-API-DMAC7.html) 2014-11-13
JP5701371B2 true JP5701371B2 (ja) 2015-04-15

Family

ID=51021385

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013268809A Active JP5701371B2 (ja) 2012-12-28 2013-12-26 スフィンゴミエリン含有サプリメント
JP2014258323A Pending JP2015083594A (ja) 2012-12-28 2014-12-22 スフィンゴミエリン含有サプリメント

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014258323A Pending JP2015083594A (ja) 2012-12-28 2014-12-22 スフィンゴミエリン含有サプリメント

Country Status (7)

Country Link
US (1) US9649322B2 (cg-RX-API-DMAC7.html)
EP (1) EP2939550B1 (cg-RX-API-DMAC7.html)
JP (2) JP5701371B2 (cg-RX-API-DMAC7.html)
CN (1) CN104883907B (cg-RX-API-DMAC7.html)
MY (1) MY171853A (cg-RX-API-DMAC7.html)
SG (1) SG11201505131UA (cg-RX-API-DMAC7.html)
WO (1) WO2014104316A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6484975B2 (ja) * 2014-09-24 2019-03-20 日油株式会社 グリセロリン脂質含有粉末および健康食品
EP4252744A4 (en) * 2020-11-30 2024-10-09 Kao Corporation SOLID COMPOSITION

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000139410A (ja) 1998-11-06 2000-05-23 Kansai Koso Kk 炊飯用カルシウム強化剤
US6441050B1 (en) * 2000-08-29 2002-08-27 Raj K. Chopra Palatable oral coenzyme Q liquid
ATE308548T1 (de) * 2000-11-07 2005-11-15 I R B Istituto Di Ricerche Bio Glycerophosphoinositol-derivate als cytosolic a2 phospholipase modulatoren
JP4568464B2 (ja) 2001-11-07 2010-10-27 雪印乳業株式会社 記憶障害予防治療剤
JP2004155682A (ja) 2002-11-05 2004-06-03 Dai Ichi Kogyo Seiyaku Co Ltd 錠剤用滑沢剤組成物
GB0322448D0 (en) * 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
RU2480474C2 (ru) 2005-04-28 2013-04-27 Энзимотек Лтд. Смеси полярных липидов, их получение и применение
AU2006254548C1 (en) * 2005-05-31 2012-09-20 Arla Foods Amba Phosphatidylserine enriched milk fractions for the formulation of functional foods
JP2007246404A (ja) 2006-03-14 2007-09-27 Snow Brand Milk Prod Co Ltd 学習能向上剤
JP5179737B2 (ja) 2005-09-22 2013-04-10 雪印メグミルク株式会社 スフィンゴミエリン含有医薬
CN101272793B (zh) 2005-09-22 2011-02-09 雪印乳业株式会社 含有鞘髓磷脂的药物、饮食品或饲料
JP2008031148A (ja) 2006-07-05 2008-02-14 Kao Corp 筋力向上剤
CN101484157B (zh) 2006-07-05 2012-02-29 花王株式会社 肌肉力量提高剂
JP5208428B2 (ja) 2007-01-30 2013-06-12 雪印メグミルク株式会社 美肌剤
JP5281268B2 (ja) 2007-10-31 2013-09-04 花王株式会社 筋力向上剤
JP5465834B2 (ja) 2008-01-15 2014-04-09 雪印メグミルク株式会社 肝機能保護剤
JP5882559B2 (ja) * 2008-08-07 2016-03-09 花王株式会社 運動機能向上剤
US20100151037A1 (en) * 2008-08-07 2010-06-17 Yivan Jiang Method for the preparation of nanoparticles containing a poorly water-soluble pharmaceutically active compound
JP2010111608A (ja) 2008-11-05 2010-05-20 Kao Corp 筋損傷抑制剤
US8268360B2 (en) 2010-08-26 2012-09-18 Kao Corporation Motor function improver

Also Published As

Publication number Publication date
US9649322B2 (en) 2017-05-16
CN104883907A (zh) 2015-09-02
EP2939550B1 (en) 2018-11-21
EP2939550A4 (en) 2016-11-02
WO2014104316A1 (ja) 2014-07-03
SG11201505131UA (en) 2015-08-28
US20150342971A1 (en) 2015-12-03
JP2014141476A (ja) 2014-08-07
CN104883907B (zh) 2017-05-17
MY171853A (en) 2019-11-05
EP2939550A1 (en) 2015-11-04
JP2015083594A (ja) 2015-04-30

Similar Documents

Publication Publication Date Title
DE69834255T2 (de) Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten
JP6014493B2 (ja) 固形状組成物
US20090304824A1 (en) Rapid-Melt Compositions, Methods of Making Same and Methods of Using Same
JP5446716B2 (ja) アルギニン及びカルニチン含有錠剤の製造方法
WO2001000883A1 (en) Oligosaccharide-supplying compositions
JP2016174616A (ja) 崩壊性組成物及び易崩壊性圧縮成型物
WO2004078171A1 (ja) 吸水性アミノ酸含有錠剤
JP5701371B2 (ja) スフィンゴミエリン含有サプリメント
TWI552754B (zh) Solid composition
JP6554034B2 (ja) カルシウム剤
US9956246B2 (en) Solid ingestible composition comprising a fat globule membrane component and water-soluble dietary fiber
JP6608193B2 (ja) 固形状組成物
JP6525586B2 (ja) 固形状組成物
JP2022003093A (ja) 圧縮成型製剤
JP2017079731A (ja) 固形状組成物
JP3142737U (ja) 健康食品
JP5816761B1 (ja) 固形状組成物
JP7129537B2 (ja) 固形状組成物
JP6669576B2 (ja) 固形状組成物
JP2016123322A (ja) 固形状組成物
JP6446265B2 (ja) 固形状組成物
JP6364347B2 (ja) 固形状組成物
US9675666B2 (en) Immediate-release tablet formulation, composition for tablets and method for manufacturing immediate-release tablet formulation
JP2003267867A (ja) テアニン含有圧縮成形物、製造方法および用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140925

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140925

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20140925

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20141015

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141021

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141222

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150210

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150217

R151 Written notification of patent or utility model registration

Ref document number: 5701371

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250